BOK Financial’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $149 | Buy |
+66
| New | +$169 | ﹤0.01% | 1154 |
|
|
2025
Q3 | – | Sell |
-66
| Closed | -$320 | – | 1208 |
|
|
2025
Q2 | $320 | Hold |
66
| – | – | ﹤0.01% | 1128 |
|
|
2025
Q1 | $97 | Hold |
66
| – | – | ﹤0.01% | 1275 |
|
|
2024
Q4 | $112 | Hold |
66
| – | – | ﹤0.01% | 1284 |
|
|
2024
Q3 | $181 | Buy |
+66
| New | +$237 | ﹤0.01% | 1343 |
|
|
2024
Q1 | – | Sell |
-67
| Closed | -$707 | – | 1328 |
|
|
2023
Q4 | $707 | Hold |
67
| – | – | ﹤0.01% | 1170 |
|
|
2023
Q3 | $800 | Hold |
67
| – | – | ﹤0.01% | 1094 |
|
|
2023
Q2 | $5.1K | Hold |
67
| – | – | ﹤0.01% | 971 |
|
|
2023
Q1 | $6.3K | Hold |
67
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q4 | $6.49K | Hold |
67
| – | – | ﹤0.01% | 890 |
|
|
2022
Q3 | $17K | Hold |
67
| – | – | ﹤0.01% | 887 |
|
|
2022
Q2 | $12K | Hold |
67
| – | – | ﹤0.01% | 905 |
|
|
2022
Q1 | $7K | Hold |
67
| – | – | ﹤0.01% | 972 |
|
|
2021
Q4 | $11K | Sell |
67
-18
| -21% | -$3.96K | ﹤0.01% | 975 |
|
|
2021
Q3 | $23K | Buy |
+85
| New | +$26K | ﹤0.01% | 947 |
|
|
2021
Q1 | $36K | Hold |
67
| – | – | ﹤0.01% | 902 |
|
|
2020
Q4 | $25K | Hold |
67
| – | – | ﹤0.01% | 901 |
|
|
2020
Q3 | $25K | Hold |
67
| – | – | ﹤0.01% | 850 |
|
|
2020
Q2 | $33K | Hold |
67
| – | – | ﹤0.01% | 845 |
|
|
2020
Q1 | $25K | Hold |
67
| – | – | ﹤0.01% | 820 |
|
|
2019
Q4 | $47K | Hold |
67
| – | – | ﹤0.01% | 922 |
|
|
2019
Q3 | $43K | Hold |
67
| – | – | ﹤0.01% | 896 |
|
|
2019
Q2 | $58K | Hold |
67
| – | – | ﹤0.01% | 893 |
|
|
2019
Q1 | $39K | Hold |
67
| – | – | ﹤0.01% | 897 |
|
|
2018
Q4 | $19K | Hold |
67
| – | – | ﹤0.01% | 872 |
|
|
2018
Q3 | $32K | Hold |
67
| – | – | ﹤0.01% | 915 |
|
|
2018
Q2 | $30K | Hold |
67
| – | – | ﹤0.01% | 909 |
|
|
2018
Q1 | $39K | Hold |
67
| – | – | ﹤0.01% | 900 |
|
|
2017
Q4 | $41K | Hold |
67
| – | – | ﹤0.01% | 910 |
|
|
2017
Q3 | $61K | Hold |
67
| – | – | ﹤0.01% | 967 |
|
|
2017
Q2 | $62K | Hold |
67
| – | – | ﹤0.01% | 868 |
|
|
2017
Q1 | $63K | Hold |
67
| – | – | ﹤0.01% | 863 |
|
|
2016
Q4 | $54K | Hold |
67
| – | – | ﹤0.01% | 866 |
|
|
2016
Q3 | $57K | Buy |
+67
| New | +$53.9K | ﹤0.01% | 864 |
|
Other funds holding TCRT
TRCT
AAP
BOK Financial's TCRT Position: Q2 2026 in Review
BOK Financial opened a new position in Alaunos Therapeutics (TCRT) in Q2 2026: 66 shares worth $149. The stake represents ﹤0.01% of the portfolio and ranks #1154 among its holdings. This is a return to the name: BOK Financial previously reported a position in TCRT as recently as Q2 2025.
BOK Financial first reported a position in TCRT in Q3 2016 and has held it in 34 quarters since. The position peaked at $63K in Q1 2017. 29 funds tracked by Wall St. Rank hold TCRT as of Q2 2026.
- BOK Financial held 66 shares of Alaunos Therapeutics worth $149 as of Q2 2026.
- Alaunos Therapeutics was a new BOK Financial position in Q2 2026.
- Alaunos Therapeutics made up ﹤0.01% of BOK Financial's portfolio in Q2 2026, its #1154 holding.
- BOK Financial first reported a position in Alaunos Therapeutics in Q3 2016 and has held it in 34 quarters since.
- BOK Financial's Alaunos Therapeutics position peaked at $63K in Q1 2017.
- 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.